Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04063969
Other study ID # B670201837824
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 24, 2019
Est. completion date August 20, 2019

Study information

Verified date November 2021
Source University Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to measure the radiation safety climate in the hybrid angiography suite using self-assessment and to investigate the relationship of radiation safety climate with their self-reported safety behaviors. The hypothesis is that a radiation safety climate does exist and can be measured using self-assessment. Additionally, it is expected that the radiation safety climate positively influences radiation safety behaviors.


Description:

Radiation safety in the hybrid angiography suite is a primordial safety component which is relevant for endovascular team members and patients. To date, many interventions which aim to improve radiation safety habits of an endovascular team focus on improving technology and team radiation safety knowledge. Safety literature has indicated that a safety climate can be identified as the shared perceptions of team members or workers about the safety in their workspace and that this safety climate is closely related to safety behaviors and outcomes. In endovascular specialties, the concept of a radiation safety climate remains unexplored. Therefore, this study aims to measure the radiation safety climate in a diverse pool of endovascular team members from different hospitals, using self-assessment questionnaires and to investigate the relationship of radiation safety climate with their self-reported safety behaviors.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date August 20, 2019
Est. primary completion date August 20, 2019
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Endovascular team member group Inclusion Criteria: - Vascular surgeon OR surgical trainee OR operating nurse - Active at one of the participating hospitals Exclusion Criteria: - No exclusion criteria apply to this study. Patient group Inclusion Criteria - Patient undergoing elective endovascular repair of infrarenal abdominal aortic aneurysm Exclusion criteria - Emergency repair (ruptured aneurysm) - Additional interventional procedures (iliac aneurysm, treatment of peripheral vessel disease)

Study Design


Intervention

Other:
Assessment of radiation safety climate
The rating tool contains 28 statements which cover 5 dimensions (Leadership, communication, commitment, resources, risk awareness) of the radiation safety climate. Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement. A composite radiation safety climate score is calculated by adding ratings on all items. Minimum scale score 28 - Maximum scale score 140
Assessment of radiation safety behavior
The rating tool contains 2 statements which cover 2 dimensions of the radiation safety behavior. Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement. A composite radiation safety behavior score is calculated by adding ratings on both items Minimum scale score 2 - Maximum scale score 10
Assessment of radiation safety knowledge and motivation
The rating tool contains 2 statements which cover the radiation safety knowledge and behavior. Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement. Minimum item score 1 - maximum item score 5
Data collection
Collection of patient-related data points Demographic information: ASA-classification, BMI Procedure related information: Procedural time, approach, contrast usage case difficulty Radiation safety parameters: Air Kerma, DAP, fluoroscopy time

Locations

Country Name City State
Belgium GZA Campus Sint Augustinus Antwerpen
Belgium AZ Sint Jan Brugge Brugge West Vlaanderen
Belgium Algemeen Ziekenhuis Maria Middelares Ghent Oost Vlaanderen
Belgium Ghent University Hospital Ghent Oost Vlaanderen
Belgium Jan Yperman Ziekenhuis Ieper West Vlaanderen

Sponsors (6)

Lead Sponsor Collaborator
University Ghent Algemeen Ziekenhuis Maria Middelares, AZ Sint-Jan AV, GZA Ziekenhuizen Campus Sint-Augustinus, Jan Yperman Ziekenhuis, University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

References & Publications (1)

Griffin MA, Neal A. Perceptions of safety at work: a framework for linking safety climate to safety performance, knowledge, and motivation. J Occup Health Psychol. 2000 Jul;5(3):347-58. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Self-assessed radiation safety climate Radiation safety climate using radiation safety climate tool Baseline measurement on study inclusion (Day 1)
Primary Self-assessed radiation safety behavior Radiation safety behavior using radiation safety behavior tool Baseline measurement on study inclusion (Day 1)
Primary Self-assessed radiation safety knowledge and motivation Radiation safety knowledge and motivation using rating tool Baseline measurement on study inclusion (Day 1)
Secondary Procedural radiation doses - Dose area product Procedural dose area product (DAP) Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
Secondary Procedural radiation doses - cumulative air kerma Procedural cumulative air kerma (CAK) Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
Secondary Procedural radiation doses - fluoroscopy time Procedural fluoroscopy time Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1